Clinical Focus

  • Healthcare Simulation
  • High-Stakes Communication
  • Human Performance Optimization
  • Neonatal Resuscitation
  • Neonatal Intensive Care
  • Neonatology

Boards, Advisory Committees, Professional Organizations

  • Member, American Academy of Pediatrics (2009 - Present)
  • Member, Society for Simulation in Healthcare (2012 - Present)
  • Member, Society for Pediatric Research (2013 - Present)
  • Member, California Association of Neonatologists (2013 - Present)

Professional Education

  • Board Certification: Neonatology, American Board of Pediatrics (2012)
  • Fellowship:Stanford University School of Medicine (06/30/2015)
  • Residency:UCSD Medical Center (2012) CA
  • Internship:UCSD Medical Center (2010) CA
  • Medical Education:Washington Univ School Of Med (2009) MO
  • Bachelor of Science, University of California Los Angeles (2004)

Stanford Advisors

Research & Scholarship

Current Research and Scholarly Interests

My research interests are in neonatal resuscitation and improving human performance within this realm. I have been drawn to neonatal resuscitation because it requires mastery of technical and behavioral skills to optimize patient outcomes. I have sought to expand my experience and expertise with simulation as an education and research modality during my postdoctoral fellowship in Neonatal-Perinatal Medicine. As such, my research is focused on the use of simulation to improve human performance in neonatal resuscitation. My research mentor, Louis Halamek, M.D., is the former program director of the neonatology fellowship program at Lucile Packard Children’s Hospital at Stanford University and the founder and medical director of the Center for Advanced Pediatric and Perinatal Education (CAPE) at Stanford. CAPE is a simulation center that provides a realistic delivery and resuscitation room with microphones, cameras, and a computerized neonatal patient simulator, separated from a control room by a one-way mirror. These facilities have been in operation since 2002 and have been used to train hundreds of healthcare providers in the complex task of neonatal resuscitation. My primary research project during fellowship is a quantitative and qualitative evaluation of the types of errors made by healthcare professionals during simulated neonatal resuscitation at CAPE, and a prospective, randomized controlled study to determine if utilization of standardized communication techniques can reduce those errors. After fellowship, I plan to secure a position as an assistant professor in neonatal intensive care at an academic institution. My academic focus will continue to be in neonatal resuscitation and the use of simulation for both education and research.


  • Determination of the rate of common deviations from the NRP algorithm and evaluation of focused strategies for remediation, CAPE at Stanford


    Palo Alto, CA


Journal Articles

  • The Neonatal Resuscitation Program: Current Recommendations and a Look at the Future. Indian journal of pediatrics Kumar, P., Yamada, N. K., Fuerch, J. H., Halamek, L. P. 2014


    The Neonatal Resuscitation Program (NRP) consists of an algorithm and curriculum to train healthcare professionals to facilitate newborn infants' transition to extrauterine life and to provide a standardized approach to the care of infants who require more invasive support and resuscitation. This review discusses the most recent update of the NRP algorithm and recommended guidelines for the care of newly born infants. Current challenges in training and assessment as well as the importance of ergonomics in the optimization of human performance are discussed. Finally, it is recommended that in order to ensure high-performing resuscitation teams, members should be selected and retained based on objective performance criteria and frequent participation in realistic simulated clinical scenarios.

    View details for DOI 10.1007/s12098-013-1332-0

    View details for PubMedID 24652267

  • When operating is considered futile: Difficult decisions in the neonatal intensive care unit SURGERY Yamada, N. V., Kodner, I. J., Brown, D. E. 2009; 146 (1): 122-125

    View details for DOI 10.1016/j.surg.2009.03.029

    View details for Web of Science ID 000267498600015

    View details for PubMedID 19548365

  • Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms AMERICAN JOURNAL OF NEURORADIOLOGY Yamada, N. K., Cross, D. T., Pilgram, T. K., Moran, C. J., Derdeyn, C. P., Dacey, R. G. 2007; 28 (9): 1778-1782


    Thromboembolic events are the most common complications of elective coil embolization of cerebral aneurysms. Administration of oral clopidogrel and/or aspirin could lower the thromboembolic complication rate.Records over a 10-year period were reviewed in a retrospective cohort study. For 369 consecutive elective coil embolization procedures, 25 patients received no antiplatelet drugs, 86 received antiplatelet drugs only after embolization, and 258 received antiplatelet drugs before and after embolization.Symptomatic thromboembolic complications (transient ischemic attack or stroke within 60 days) occurred in 4 (16%) of 25 when no antiplatelet drugs were given, in 2 (2.3%) of 86 when antiplatelet drugs were administered only after embolization, and in 5 (1.9%) of 258 when antiplatelet drugs were administered before and after embolization. The lower symptomatic thromboembolic complication rate in the patients who received any antiplatelet therapy was statistically significant (P = .004). Clots were visible intraprocedurally in 5 (4.5%) of 111 when no antiplatelet drugs were administered before procedures and in 4 (1.6%) of 258 when they were (P value not significant). None of the 9 was symptomatic postprocedurally, but 7 were lysed or mechanically disrupted. Extracerebral hemorrhagic complications occurred in 0 (0%) of 25 when no antiplatelet drugs were given and in 11 (3.2%) of 344 when they were (P value not significant).Oral clopidogrel and/or aspirin significantly lowered the symptomatic thromboembolic complication rate of elective coil embolization of unruptured cerebral aneurysms. There were trends toward a lower rate of intraprocedural clot formation in patients given antiplatelet drugs before procedures and a higher hemorrhagic complication rate in patients given antiplatelet drugs. Benefits of antiplatelet therapy appear to outweigh risks.

    View details for DOI 10.3174/ainr.A0641

    View details for Web of Science ID 000250312200035

    View details for PubMedID 17885244

Stanford Medicine Resources: